Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hyperbolic Holdings is a private Swiss healthcare-focused holding company, investment firm, and strategy advisory business based in Lugano. The company focuses on life science and healthcare sectors including biotech, medtech, diagnostics, therapeutics, nutraceuticals, cosmeceuticals, and health services. Its activities center on deal sourcing, due diligence, portfolio construction, business development, market expansion, licensing and M&A advisory rather than developing its own therapeutic pipeline. Hyperbolic Holdings appears to serve investors, healthcare businesses, and innovators by providing strategic access to opportunities across international healthcare markets. The firm presents itself as an active specialist in healthcare life sciences with a global partner network and an emphasis on transactions and growth initiatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hyperbolic Holdings.